A Transformative Opportunity to Repurpose Validated Oncology Drugs
In an increasingly competitive oncology landscape, drug developers are looking to extend the value of existing assets and unlock new therapeutic potential. Molecular Radiotherapy (MRT) offers a powerful approach, conjugating radioisotopes to validated targeting molecules (antibodies, peptides, small molecules) to deliver cytotoxic radiation directly to tumors, with minimal impact on healthy tissue.
At Oncodesign Services, we’ve been advancing MRT technologies since 2008, combining deep expertise in oncology, radiochemistry, and pharmacology under one roof. Whether you’re looking to enhance efficacy, expand indications, or revitalize shelved compounds, our integrated radiopharmaceutical platforms are built to support you from feasibility to IND-enabling studies.
Download our technical sheet to explore:
- MRT strategy for drug repurposing
- Key capabilities for radioconjugate design
- Imaging, biodistribution, and dosimetry services
- Regulatory and translational support for MRT development
Ready to see if your molecule is MRT-ready? Download the technical sheet and discover how we help your team move faster and smarter in radiopharmaceutical development.
